Alzheimer's Disease

Showing NaN - NaN of 102

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Alzheimer's Disease Trial in United States (LY451395, Placebo)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +16 more
Oct 23, 2017

Alzheimer's Disease Trial in Worldwide (Rosiglitazone Extended Release 2mg, Rosiglitazone Extended Release 8mg, Placebo)

Completed
  • Alzheimer's Disease
  • Rosiglitazone Extended Release 2mg
  • +3 more
  • Litchfield Park, Arizona
  • +248 more
Oct 23, 2017

Alzheimer's Disease Trial in Worldwide (Rosiglitazone XR)

Terminated
  • Alzheimer's Disease
  • Rosiglitazone XR
  • Litchfield Park, Arizona
  • +271 more
Oct 11, 2017

Alzheimer's Disease Trial in Worldwide (Placebo, Idalopirdine)

Completed
  • Alzheimer's Disease
  • Birmingham, Alabama
  • +136 more
Aug 22, 2017

Alzheimer's Disease Trial in Worldwide (MABT5102A, )

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +91 more
Jul 10, 2017

Alzheimer's Disease Trial in France, Spain, United States (MABT5102A, )

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +28 more
Jul 10, 2017

Alzheimer's Disease Trial in Canada, United States (rosiglitazone)

Completed
  • Alzheimer's Disease
  • Litchfield Park, Arizona
  • +6 more
Apr 18, 2017

Alzheimer's Disease Trial in Worldwide (Rosiglitazone)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +137 more
Apr 13, 2017

Alzheimer's Disease Trial in United States (Dimebon, Placebo)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +27 more
Sep 24, 2016

Alzheimer's Disease Trial in Worldwide (Dimebon, Placebo comparator)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +100 more
Sep 24, 2016

Alzheimer's Disease Trial in France, Italy, United States (florbetapir (18F))

Completed
  • Alzheimer's Disease
  • florbetapir (18F)
  • Phoenix, Arizona
  • +56 more
Jul 8, 2016

Alzheimer's Disease, Stroke, Parkinson's Disease Trial in United States (AVP-923)

Completed
  • Alzheimer's Disease
  • +3 more
  • Phoenix, Arizona
  • +38 more
Jul 13, 2016

Alzheimer's Disease Trial in United States (Resveratrol, Placebo)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +25 more
May 6, 2016

Alzheimer's Disease, Dementia Trial in Worldwide (EVP-6124)

Terminated
  • Alzheimer's Disease
  • Dementia
  • Phoenix, Arizona
  • +85 more
May 2, 2016

Alzheimer's Disease, Dementia Trial in Worldwide (Drug: EVP-6124, Placebo)

Terminated
  • Alzheimer's Disease
  • Dementia
  • Drug: EVP-6124
  • Placebo
  • Phoenix, Arizona
  • +81 more
May 2, 2016

Alzheimer's Disease Trial in United States (ACC-001 3 µg/ QS-21 50 µg, ACC-001 10 µg/ QS-21 50 µg, Placebo- Phosphate buffered

Completed
  • Alzheimer's Disease
  • ACC-001 3 μg/ QS-21 50 μg
  • +2 more
  • Phoenix, Arizona
  • +39 more
Jan 28, 2016

Alzheimer's Disease Trial in Phoenix, Sun City (dimebon)

Terminated
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +3 more
Nov 13, 2015

Alzheimer's Disease Trial in Worldwide (BMS-708163, Placebo)

Completed
  • Alzheimer's Disease
  • Birmingham, Alabama
  • +40 more
Sep 23, 2015

Alzheimer's Disease Trial in Worldwide (Avagacestat, Placebo)

Terminated
  • Alzheimer's Disease
  • Birmingham, Alabama
  • +63 more
Sep 23, 2015

CHF, Diabetes, Coronary Artery Disease Trial in United States (Care Coordination)

Unknown status
  • Congestive Heart Failure
  • +8 more
  • Care Coordination
  • Phoenix, Arizona
  • +14 more
Sep 29, 2015

Alzheimer's Disease Trial in Worldwide (Donepezil, AZD3480)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +32 more
May 11, 2015

Alzheimer's Disease Trial in Worldwide (LY450139, Placebo)

Completed
  • Alzheimer's Disease
  • Birmingham, Alabama
  • +147 more
Mar 13, 2015

Alzheimer's Disease Trial in Worldwide (LY450139, Placebo)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +90 more
Jan 28, 2015

Alzheimer's Disease Trial in Worldwide (semagacestat)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +70 more
Sep 22, 2014

Alzheimer's Disease Trial in United States (DHA (Docosahexaenoic Acid), Placebo)

Completed
  • Alzheimer's Disease
  • DHA (Docosahexaenoic Acid)
  • Placebo
  • Birmingham, Alabama
  • +50 more
Sep 15, 2014